I agree that this site is using cookies. You can find further informations here.
X
Yap, Timothy
673  results:
Search for persons X
?
1

Experimental investigation and validation of strength-based..:

Yap, Timothy ; He, Zhelong ; Wang, Zhichao..
Additive Manufacturing.  89 (2024)  - p. 104274 , 2024
Link: https://doi.org/10.1016/..
 
?
2

The Family that Eats Together Stays Together: Food and Kins..:

Yap, Timothy
Scandinavian Journal of the Old Testament.  38 (2024)  1 - p. 96-108 , 2024
Link: https://doi.org/10.1080/..
 
?
3

Targeting DNA Damage Response Deficiency in Thoracic Cancer:

Bzura, Aleksandra ; Spicer, Jake B. ; Dulloo, Sean..
Drugs.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

Limited Independent Follow-Up with Germline Testing of Vari..:

Nowlen, Carol J. ; Daniels, Molly ; Uzunparmak, Burak...
Journal of Immunotherapy and Precision Oncology.  7 (2024)  1 - p. 7-17 , 2024
Link: https://doi.org/10.36401..
 
?
5

First-in-Human Study of the Ataxia Telangiectasia and Rad3-..:

Yap, Timothy A. ; Tolcher, Anthony W. ; Plummer, Ruth...
Clinical Cancer Research.  30 (2024)  10 - p. 2057-2067 , 2024
Link: https://doi.org/10.1158/..
 
?
6

Long-Term Echocardiographic and Clinical Outcomes After Inv..:

Robinson, Hayley ; Anstey, Matthew ; Litton, Edward...
Heart, Lung and Circulation.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Targeting ATR in patients with cancer:

Ngoi, Natalie Y. L. ; Pilié, Patrick G. ; McGrail, Daniel J....
Nature Reviews Clinical Oncology.  21 (2024)  4 - p. 278-293 , 2024
Link: https://doi.org/10.1038/..
 
?
8

Ataxia telangiectasia and Rad3-related (ATR) inhibitor camo..:

Fontana, Elisa ; Rosen, Ezra ; Lee, Elizabeth K...
JNCI: Journal of the National Cancer Institute.  , 2024
Link: https://doi.org/10.1093/..
 
?
9

Targeting ATR in Cancer Medicine:

, In: Targeting the DNA Damage Response for Cancer Therapy; Cancer Treatment and Research,
Salguero, Carolina ; Valladolid, Christian ; Robinson, Helen M. R... - p. 239-283 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Impact of Biomarker-Matched Therapies on Outcomes in Patien..:

Carmagnani Pestana, Roberto ; Moyers, Justin T. ; Roszik, Jason...
Clinical Cancer Research.  29 (2023)  9 - p. 1708-1718 , 2023
Link: https://doi.org/10.1158/..
 
?
11

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB..:

Knisely, Anne ; Ahmed, Jibran ; Stephen, Bettzy...
Cancer.  130 (2023)  3 - p. 400-409 , 2023
Link: https://doi.org/10.1002/..
 
?
12

Phase I study of sapanisertib with carboplatin and paclitax..:

Alhalabi, Omar ; Groisberg, Roman ; Zinner, Ralph...
npj Precision Oncology.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Complex I inhibitor of oxidative phosphorylation in advance..:

Yap, Timothy A. ; Daver, Naval ; Mahendra, Mikhila...
Nature Medicine.  , 2023
Link: https://doi.org/10.1038/..
 
?
14

SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid ..:

Drilon, Alexander ; Sharma, Manish R. ; Johnson, Melissa L....
Cancer Discovery.  13 (2023)  8 - p. 1789-1801 , 2023
Link: https://doi.org/10.1158/..
 
?
15

Exploiting metabolic vulnerabilities after anti-VEGF antibo..:

Glassman, Deanna ; Kim, Mark S. ; Spradlin, Meredith...
iScience.  26 (2023)  2 - p. 106020 , 2023
Link: https://doi.org/10.1016/..
 
1-15